Akito Kakuuchi

发表

Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives.

K. Shinozaki, T. Matsushita, A. Naganawa, 2016, Bioorganic & medicinal chemistry letters.

Discovery of novel S1P2 antagonists. Part 2: Improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives.

K. Shinozaki, T. Matsushita, A. Naganawa, 2015, Bioorganic & medicinal chemistry letters.

Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives.

K. Shinozaki, T. Matsushita, T. Kanaji, 2015, Bioorganic & medicinal chemistry letters.

Synthesis of 2-fluoro analog of 6-aminonorbornane-2,6-dicarboxylic acid: A conformationally rigid glutamic acid derivative

A. Saito, Hisanaka Ito, T. Taguchi, 1999 .

Pd-catalyzed regioselective acylation of α,β-unsaturated ketone derivatives by acylzirconocene chloride as an acyl group donor

Y. Hanzawa, T. Taguchi, Akito Kakuuchi, 2002 .

Rh(I)-catalyzed addition of alkenylzirconocene chlorides to aldimine derivatives

Y. Hanzawa, T. Taguchi, Akito Kakuuchi, 2003 .

Rh(I)-catalyzed conjugate addition of alkenylzirconocene chloride: stereoselective formation of carbocycles through cascade reaction

A. Saito, Y. Hanzawa, H. Fukaya, 2007 .

Rhodium-catalyzed 1,4-addition of alkenylzirconocene chlorides to electron deficient alkenes

Y. Hanzawa, T. Taguchi, Akito Kakuuchi, 2004 .

Synthesis and evaluation of a potent, well-balanced EP2/EP3 dual agonist.

A. Naganawa, M. Higashino, Hiroyuki Takeda, 2018, Bioorganic & medicinal chemistry.

Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.

M. Higashino, H. Matsuya, K. Ohmoto, 2016, Bioorganic & medicinal chemistry letters.

Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan

K. Tobinai, Ayumi Akamatsu, Akito Kakuuchi, 2024, International journal of hematology.